SACRAMENTO, Calif., Dec. 18 /PRNewswire/ -- LifeWave, Inc. announced today the appointment of Franklin M. Beninsig, a transaction due diligence specialist with an expertise in technology transfer and high technology intellectual property estates, as the company's Vice President of Licensing and Intellectual Property.
Mr. Beninsig started in 1978 at the University of California, Davis being involved with the initial development of technology transfer groups. In 1986 Mr. Beninsig began private practice as an intellectual property specialist and litigation coordinator for clients such as Baxter and Dade Behring. Mr. Beninsig has served as an intellectual property expert or litigation/discovery coordinator for several nationally known law firms including Fish & Richardson, PC. He has a worldwide network of affiliations and contacts to assist him in business transaction due diligence and intellectual property estate expansion focusing on medical device technologies. In particular, for Baxter, Mr. Beninsig coordinated the due diligence and technology transfer process for several of the company's major acquisitions, spinouts and divestitures (e.g. Dade Behring). He is also a co-inventor in several point-of-care and near-patient medical technology inventions.
Mr. Beninsig's primary responsibilities will include the immediate launching of LifeWave's LifeScanner licensing program for medical devices and the rapid expansion of LifeWave's intellectual property estates. LifeWave has licensed 27 issued global patent families from the Lawrence Livermore Laboratories covering diversified uses of ultra-wideband radar and is developing broad technology holdings estates for both military and civilian use of such radar.
"As we move forward in the rapid innovation of battlefield life saving technologies, LifeWave anticipates that no single company will have the ability and know-how to introduce products quickly into the mainstream healthcare system. We look forward to having Mr. Beninsig's technology management expertise and medical device experience to assist LifeWave in both the introduction of our battlefield products and the expansion of such products into the public markets," commented Dr. Joe Tupin, co-founder of LifeWave and retired executive physician for the University of California.
The LifeScanner device is a non-invasive, non-contact medical radar for cardiopulmonary evaluation, monitoring, and management. LifeWave completed its first Army contract and delivered prototype sensors to the Army's Walter Reed Combat Casualty Care Program in 2003. The sensors proved able to detect cardiopulmonary activities through flak jackets and will be clinically evaluated 2004. Additionally, LifeWave entered into a Space Act Agreement with NASA to develop a robust sensor that does not require skin contact for integration into NASA's health monitoring systems. The National Technology Transfer Center is also currently evaluating the LifeScanner for mass casualty triage and rescuer monitoring.
Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements and involve risks and uncertainties. They include the news release originator's reliance on their collaborative partners and their ability to properly design, implement and complete clinical trial; meet regulatory requirements; demonstrate safety and efficacy of products; manage third-party contracts; and avoid infringement of third-party proprietary rights. Actual results may differ materially from those projected. These forward-looking statements represent the originator's best judgment as of the cited date of the release. We disclaim any intent or obligation to update these forward-looking statements.
CONTACT: John Tupin, SVP Strategic Planning and Business Development ofLifeWave, Inc., +1-916-781-6500, or firstname.lastname@example.org